Publisher
Springer Science and Business Media LLC
Reference38 articles.
1. Veltman JA, Brunner HG. De novo mutations in human genetic disease. Nat Rev Genet. 2012;13:565–75.
2. Yoshimi K, Kaneko T, Voigt B, Mashimo T. Allele-specific genome editing and correction of disease-associated phenotypes in rats using the CRISPR–Cas platform. Nat Commun. 2014;5:4240–58.
3. Ishino Y, Krupovic M, Forterre P. History of CRISPR–Cas from encounter with a mysterious repeated sequence to genome editing technology. J Bacteriol. 2018.
https://doi.org/10.1128/JB.00580-17
.
4. Scharf I, Bierbaumer L, Huber H, Wittmann P, Haider C, Pirker C, Berger W, Mikulits W. Dynamics of CRISPR/Cas9-mediated genomic editing of the AXL locus in hepatocellular carcinoma cells. Oncol Lett. 2018;15(2):2441–50.
5. Motta BM, Pramstaller PP, Hicks AA, Rossini A. The impact of CRISPR/Cas9 technology on cardiac research: from disease modelling to therapeutic approaches. Stem Cells Int. 2017.
https://doi.org/10.1155/2017/8960236
.
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献